However, the role of GABARAPL1 is controversial with a study showing that downregulation of GABARAPL1 suppresses tumorigenesis and metastasis in triple negative breast cancer cells (15). This evidence concerns the gene GABARAPL1 and triple-negative breast carcinoma.